Sign in

Filings

Finds words inside filing documents. Searching SAB Biotherapeutics, Inc.'s filings · 32 documents indexed.

4 documents · 13 matches

  1. SABS SAB Biotherapeutics, Inc. 10-Q 2026-11-05

    Item 1. Condensed Consolidated Financial Statements (Unaudited).

    going concern rather than face dissolution before 2028. The probability of survival was 70.0% and 40.0% as of September 30, 2026 and December
    1 match in this document
  2. SABS SAB Biotherapeutics, Inc. 10-Q 2026-08-06

    Item 1. Condensed Consolidated Financial Statements (Unaudited).

    going concern rather than face dissolution before 2028. The probability of survival was 57.5% and 40.0% as of June 30, 2026 and December
    1 match in this document
  3. SABS SAB Biotherapeutics, Inc. 10-K 2026-03-09

    Item 16.

    our ability to continue as a going concern.
    2 matches in this document
  4. SABS SAB Biotherapeutics, Inc. 10-Q 2025-05-09

    Item 1. Condensed Consolidated Financial Statements (Unaudited).

    Liquidity and Going Concern
    9 matches in this document

Page 1 of 1 · 4 documents